Freenome, Inc. - Common stock (FRNM)
9.9300
+0.1100 (1.12%)
NASDAQ · Last Trade: Nov 18th, 11:59 AM EST
Freenome (FRNM) Q3 2026 Earnings Call Transcriptfool.com
Freenome's first public quarter brings a $180 million FDA-driven revenue jump.
Via The Motley Fool · November 17, 2026
Freenome Q3 Earnings Call Highlightsmarketbeat.com
Freenome (NASDAQ:FRNM) reported third-quarter revenue of $183.5 million, driven largely by revenue recognition following the U.S. Food and Drug Administration’s approval of its blood-based colorectal cancer screening test. The company said it does not expect meaningful testing revenue or royalties i
Via MarketBeat · November 10, 2026
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Boughtfool.com
Ark Invest added to three existing positions on Monday, all of them down sharply from recent highs.
Via The Motley Fool · October 20, 2026